Table 1 Characteristics of the patient population
From: The significance of low PU.1 expression in patients with acute promyelocytic leukemia
Patient no | Age | Sex | Blasts (%) | WBC (×109/L) | HGB (g/L) | Platelets (×109/L) | Karyotype |
|---|---|---|---|---|---|---|---|
APL1 | 53 | M | 92.5 | 4.9 | 105 | 64 | 46,XY,t(15;17)(q22;q12)[7]/ 46,XY[2] |
APL2 | 47 | M | 82 | 3.3 | 100 | 7 | 46,XY,t(15;17)(q22;q12) |
APL3 | 31 | M | 91 | 15.1 | 100 | 17 | ND |
APL4 | 65 | M | 95.5 | ND | ND | ND | 46,XY,t(15;17)(q22;q12)[8]/ 46,XY[3] |
APL5 | 34 | M | 97.5 | 2.04 | 57 | 45 | 46,XY,t(15;17)(q22;q12) |
APL6 | 51 | F | 91 | 3.9 | 78 | 71 | 46,XX,t(15;17)(q22;q12)[9] |
APL7 | 58 | F | 85.5 | 5.6 | 101 | 62 | 46,XX,t(15;17)(q22;q12)[10]/ 46,XX[11] |
APL8 | 34 | F | 98 | 7.5 | 117 | 34 | 46,XX,t(15;17)(q22;q12)[10]/ 46,XX[11] |
APL9 | 40 | M | 85.5 | 5.7 | 69 | 30 | 46,XY,t(15;17)(q22;q12)[12]/ 46,XY[3] |
APL10 | 24 | M | 91 | 2.5 | 122 | 60 | 46,XY,t(15;17)(q22;q12) |